• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

IFITM3 rs12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysis

tetano

Editor, Senior Moderator
Epidemiol Infect. 2015 Mar 17:1-10. [Epub ahead of print]
[h=1]IFITM3 rs12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysis.[/h] Xuan Y[SUP]1[/SUP], Wang LN[SUP]1[/SUP], Li W[SUP]2[/SUP], Zi HR[SUP]1[/SUP], Guo Y[SUP]1[/SUP], Yan WJ[SUP]1[/SUP], Chen XB[SUP]1[/SUP], Wei PM[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The interferon-inducible transmembrane protein 3 (IFITM3), as one of the key genes involved in the interferon pathway, is critical for defending the host against influenza virus, and the rs12252 T>C variant in IFITM3 might be associated with susceptibility to severe influenza. Owing to contradictory and inconclusive results, we performed a meta-analysis to assess the association between rs12252 T>C polymorphism and severe influenza risk. A comprehensive literature search up to 1 August 2014 was conducted in EMBASE, Pubmed, Web of Science, VIP, Wanfang and CNKI databases. Four eligible studies with a total of 445 influenza patients and 3396 controls were included in this meta-analysis. Overall, our results demonstrated a significant association between the IFITM3 rs12252 T>C polymorphism and influenza risk [C vs. T: odds ratio (OR) 1?68, 95% confidence interval (CI) 1?32-2?13; CC vs. CT+TT: OR 2?38, 95% CI 1?52-3?73; CC+CT vs. TT: OR 1?62, 95% CI 1?18-2?22]. Stratification by ethnicity indicated that the variant C allele was associated with an 88% increased risk of influenza in Asians (C vs. T: OR 1?88, 95% CI 1?34-2?62). Moreover, subjects carrying the variant C allele had an increased risk of developing severe illness upon influenza infection (C vs. T: OR 2?70, 95% CI 1?86-3?94). However, no significant association was observed in patients with mild infection (C vs. T: OR 1?26, 95% CI 0?93-1?71). Our meta-analysis suggests that IFITM3 rs12252 T>C polymorphism is significantly associated with increased risk of severe influenza but not with the chance of initial virus infection.


[h=4]KEYWORDS:[/h] polymorphism

PMID: 25778715 [PubMed - as supplied by publisher]
 
Back
Top Bottom